Did you know that one in five adults in the United States experiences a mental illness in a given year?
From depression to other psychiatric disorders, treatments have varied throughout the years with inconsistent results. Well, Ybrain aims to change that with their innovate healthcare through neuromodulation devices based on non-invasive technologies.
They are specialized in treating degenerative brain diseases such as Parkinson’s disease, Alzheimer, dementia, and impaired motor function disease.
The current stimulation therapy induces the frontal lobe normalization and reduces the symptoms of mild cognitive impairment and mood disturbance, which are mainly caused by the malfunctioning of the frontal lobe.
MINDD is a safe and user-friendly medical device, thus, it is convenient for doctors to provide the therapy simultaneously to many patients and also for the patients to have domiciliary treatment.
So, this pilot trial will show if patients like the procedure or patients like the method, and also, whether the specific at home tDCS can actually be efficacious for mood disturbances.
To learn more about the innovative technologies that YBrain is providing to patients of mental illness, head on over to ybrain.com today.